← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2015Last known activity
Nov 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (71 distinct, 48 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07250230OfficialN/ANov 30, 2025
- NCT07250230Lead sponsorN/ANov 30, 2025
- NCT07268872Lead sponsorN/ANov 21, 2025
- NCT07206745CollaboratorN/AOct 1, 2025
- NCT07112157Lead sponsorN/AAug 31, 2025
- NCT07128251CollaboratorPhase 2Aug 20, 2025
- NCT07097038Lead sponsorN/AJul 31, 2025
- NCT07002346CollaboratorPhase 3Jun 1, 2025
- NCT07104149CollaboratorPhase 2Mar 10, 2025
- NCT06737913CollaboratorPhase 2Dec 31, 2024
- NCT06668298Lead sponsorN/ANov 30, 2024
- NCT06693362CollaboratorPhase 1Nov 11, 2024
- NCT06588335Lead sponsorPhase 2Sep 30, 2024
- NCT06561308CollaboratorPhase 2Sep 1, 2024
- NCT06538883CollaboratorN/AAug 1, 2024
Details
- Last known activity
- Nov 30, 2025